• Explore /
  • Poster
  • / Neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab to de-escalate surgery and omit adjuvant radiation in locoregionally advanced head & neck squamous cell carcinoma (HNSCC).

Neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab to de-escalate surgery and omit adjuvant radiation in locoregionally advanced head & neck squamous cell carcinoma (HNSCC).

Abstract Poster

Authors

null

Winston Wong

Memorial Sloan Kettering Cancer Center, New York, NY

Winston Wong , Jennifer R. Cracchiolo , Nadeem Riaz , Ian Ganly , Eric Jeffrey Sherman , Alan Loh Ho , Luc Morris , Ronald A Ghossein , Sofia Haque , Kin Wai (Tony) Hung , Anuja Kriplani , Marc Cohen , Jay Boyle , Sean Matthew McBride , Daphna Y. Gelbum , Loren S. Michel , Nancy Y. Lee , Richard J. Wong , David G. Pfister , Lara Dunn

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT04722523

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 6019)

DOI

10.1200/JCO.2023.41.16_suppl.6019

Abstract #

6019

Poster Bd #

11

Abstract Disclosures

Similar Posters

Poster

2020 Gastrointestinal Cancers Symposium

A phase II study of neoadjuvant chemotherapy with DCS for resectable advanced esophageal cancer.

A phase II study of neoadjuvant chemotherapy with DCS for resectable advanced esophageal cancer.

First Author: Junya Kitadani

First Author: Xue-ning Yang

First Author: Rejin Kebudi

First Author: Thomas Ruhstaller